ABIGAIL CZARNECKI: Open Payments
NPI 1124783006 · WAUWATOSA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 23 payments from 10 companies in 2025. Trend: 2023 $726 · 2024 $498 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $177 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| Alkermes, Inc. | 3 | $88 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Indivior Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Tris Pharma Inc | 1 | $19 |
| Corium, LLC | 1 | $14 |
Products named: MAVYRET, FANAPT, ARISTADA, VRAYLAR, REXULTI, SUBLOCADE, LYBALVI, SPRAVATO.
Industry payments across WI — which companies pay providers there.
